Our Human Products
Antibacterial Antifungal |
||||
S.N. | Product Name | Label claim | Pack Size | Action & Use |
ANTIBACTERIAL ANTIFUNGAL, ANTISCABIES EXTERNAL LIQUIDS | ||||
1 | Formulation 1 | Contains | 100 ml | Anteseptic Liquid |
Chlorhexidine Gluconate IP 0.3% v/v | 500 ml | |||
Cetrimide IP 0.06% w/v | 1000 ml | |||
Colour Tatrazine & Sunset Yellow FCF | 5 Ltr | |||
2 | Formulation 2 | Contains | 5000 ml | Anteseptic Liquid |
Chlorhexidine Gluconate BP 20% v/v | ||||
Solution Eq. To chlorhexidine Gluconate | ||||
IP 4 % w/v | ||||
Colour: Carmoisine | ||||
3 | Formulation 3 | Each 100ml Contains: | 500ml | Anteseptic Liquid |
Chlorhexidine Gluconate 0.3g | ||||
Cetrimide 3.0g | ||||
n-Propyl Alcohol (as preservative) 2.84% m/v | ||||
4 | Formulation 4 | 2-Propanol 70% v/v BP | 100ml | |
5 | Formulation 5 | Contains | 500 ml | Anteseptic Liquid |
Chlorhexidine Gluconate BP 5 % | ||||
Solution ( Dilute ) | ||||
6 | Formulation 6 | Contains | 100 ml | Anteseptic Liquid |
Chloroxylenol BP 3% w/v | ||||
Terpineol BP 2% w/v | ||||
Soap/Detergent base | ||||
7 | Formulation 7 | Contains | 100 ml | Antiseptic |
Chloroxylenol BP 3% w/v | Germicidal | |||
Chlorhexidine Gluconate BP 0.3% v/v | (Topical Skin | |||
strong Cetrimides solution Eq.to | infection,irrigation | |||
Cetrimide 0.4 % w/v | of wounds surgical | |||
infection & also | ||||
disinfectant ) | ||||
8 | Formulation 8 | Each gm Contains | 500 gm | Antiseptic |
Dicloroxylenol IP 1% w/w | ||||
Terpineol BP 1% w/w | ||||
Phenol IP 0.25 % | ||||
In Lubricant base | ||||
9 | Formulation 9 | Contains | 25 gm | Antiseptic |
Chloroxylenol USP 0.6% w/v | (used for topicaol | |||
Chlorhexidine Gluconate | antiseptic on minor | |||
solution BP 0.3% w/w | burns,wounds skin | |||
cream base | infections,surgical | |||
infection) | ||||
10 | Formulation 10 | Contains | 25 gm | Antibacterial |
Cetrimide BP 0.5 % w/w | ||||
Chlorhexidine Gluconate | ||||
solution BP 0.1% w/w | ||||
( Eq. To Chlorhexidine Gluconate) | ||||
Water miscible cream base Q.S. | ||||
11 | Formulation 11 | Chloroxylenol IP 3% | 100ml | Antiseptic |
Chlorhexidine Gluconate Solution IP 0.3% | 500ml | (used for topicaol | ||
Strong Cetrimide Solution equivalent to | 1ltr | antiseptic on minor | ||
Cetrimide IP 0.4% w/v | burns,wounds skin | |||
infections,surgical | ||||
infection) | ||||
12 | Formulation 12 | Chlorooxylenol IP 0.6% w/w | 25gm | Antiseptic Cream |
Chlorhexidine Gluconate Solution IP 0.3% w/w | ||||
Cream base Q.s | ||||
13 | Formulation 13 | Composition : | 25gm | Antiseptic Cream |
Chlorhexidine Gluconate Solution BP | ||||
Equivalent to Chlorhexidine Gluconate 1% w/w | ||||
14 | Formulation 14 | Contains | 100 ml | Antimicrobial |
Povidone – Iodine IP 5% w/v | 500 ml | Antibacterial | ||
(Available Iodine 0.5% w/v) | ||||
Povidone Iodine USP 7.5% w/v | 500ml | Antimicrobial | ||
Antibacterial | ||||
15 | Formulation 15 | Contains | 30 ml | Antimicrobial |
Povidone –Iodine IP 5% w/v | 100ml | Antibacterial | ||
( Available Iodine 0.5% w/v ) | ||||
Metronidazole IP 1% w/v | ||||
Purified Water IP | ||||
16 | Formulation 16 | Povidone-Iodine USP 10.0% w/v | 100ml | |
17 | Formulation 17 | Each gm Contains | 4 gm | Antimicrobial |
Povidone Iodine IP 5% w/w | 15 gm | Antibacterial | ||
(Available Iodine 0.5% w/w ) | ||||
Metronidazole IP 1% w/w | ||||
Water Soluble Ointment base q.s. | ||||
18 | Formulation 18 | Contains | 2 Ltr | Antiscabies |
Gamabenzene Hexachloride IP 1% w/v | Scabicide/ | |||
Cetrimide IP 0.1% w/v | Pediculocide | |||
Benzocaine IP 06% w/v | (Scabies, | |||
Pediculosis) | ||||
19 | Formulation 19 | Salicylic Acid BP 10% w/v | 100ml | Keratolytic, anti-dandruff |
Potassium Iodide BP 1.25% w/v | sporotrichosis | |||
Iodine BP 1.25% w/v | ||||
20 | Formulation 20 | Composition: | 50gm | |
Gamabenzene Hexachloride BP 1% w/v | 2 Ltr | Antiscabies | ||
Scabicide/ | ||||
Gamma Benzene Hexachloride BP 1% w/w | Pediculocide | |||
(Scabies, | ||||
Pediculosis) | ||||
21 | Formulation 21 | Contains | 100 ml | Acaricide |
Benzyl Benzoate BP 25 % w/v | 500 ml | (Scabies, | ||
Emulsifying wax 2% | 1000 ml | Pediculosis) | ||
22 | Formulation 22 | Benzyl Benzoate BP 25% w/v | 100 ml | Acaricide |
500 ml | (Scabies, | |||
1000 ml | Pediculosis) | |||
23 | Formulation 23 | Composition: | 50 gm | Antiscabies |
Gama Benzene Hexachloride BP 1 w/v | ||||
24 | Formulation 24 | Each gm contain | 20 gm | Antifungal |
Ketoconazole USP 2% w/w | ||||
cream base Q.S. | ||||
25 | Formulation 25 | Each gm Contains: | 20 gm | Antifungal |
Ketoconazole BP 20mg | ||||
Excipients q.s. | ||||
26 | Formulation 26 | Ketoconazole BP 2% w/v | 75ml | Antifungal |
27 | Formulation 27 | Composition: | 100ml | Antifungal, anti dandruff |
Ketoconazole BP 2% w/v | ||||
Zinc Pyrithione (ZPTO) 1% w/v | ||||
Base q.s | ||||
28 | Formulation 28 | Each ml contain | 100 ml | Antifungal |
Ketoconazole USP 2% w/w | ||||
29 | Formulation 29 | Each ml Contains: | 100 ml | Antifungal |
Ketoconazole BP 10mg | ||||
Excipients q.s. | ||||
30 | Formulation 30 | Each ml Contains: | 100 ml | Antifungal |
Ketoconazole BP 20mg | ||||
Excipiens q.s. | ||||
31 | Formulation 31 | Salicylic Acid IP 2% w/v | Antifungal | |
Zinc Pyrithione 1% w/v | ||||
Colour: Ponceaur 4R | ||||
32 | Formulation 32 | Salicylic Acid IP 6% w/v | Antifungal | |
Colour: Sunset Yellow FCF | ||||
33 | Formulation 33 | Salicylic Acid IP 2% w/v | Antifungal | |
Colour Brilliant Blue FCF | ||||
34 | Formulation 34 | Each gm Contains | 20 gm | Antifungal |
Nystatin USP 100000 IU | ||||
Ointment Base Q.S. | ||||
35 | Formulation 35 | Each 4gms contains | 25gm | Antifungal |
Nystatin USP 100000IU | ||||
36 | Formulation 36 | Contains | 5 gm | Antifungal |
Clotrimazole IP 1% w/w | 10 gm | Antibacterial | ||
Beclomethasone Dipropinate IP 0.025 w/w | ||||
Gentamicin Sulphate IP | ||||
e. q. to Gentamicin base | ||||
( 1000 u / mg) 0.1% w/w | ||||
Cream Base q.s | ||||
37 | Formulation 37 | Composition: | 30 gm | Antifungal |
Clotrimazole IP 1% w/w | 5 gm | Antibacterial | ||
Neomycin Sulphate IP | ||||
e.q. to Neomycin 0.5% w / w | ||||
Beclomethasone Dipropinate IP 0.025 w/w | ||||
Cream Base Q.S. | ||||
Preservative | ||||
Sodium Methyl Paraben IP 0.25% w/w | ||||
Propyl Paraben IP 0.025% w/w | ||||
38 | Formulation 38 | Each gm contains | 15 gm | Topical |
Betamethasone Dipropinate USP 0.643 mg | 30gm | Antifungal | ||
Gentamycin Solphate | Antibacterial | |||
Gentamycin base 1mg | (Fungal &bacterial | |||
Tolnaftate USP 10mg | skin infection) | |||
Iodochlorohydroxy quinoline 10mg | ||||
Chlorocrosol B 1mg | ||||
cream base | ||||
39 | Formulation 39 | Clotrimazole USP 1% w/w | 15gm | Topical |
Betamethasone Dipropionate USP | Antifungal | |||
Eqvt. To Betamethasone 0.05% w/w | Antibacterial | |||
Neomycin Sulphate USP | (Fungal &bacterial | |||
eq. to Neomycin 0.35% w/w | skin infection) | |||
Chlorocresol USP (as preservative) 0.1% w/w | ||||
Cream Base q.s | ||||
40 | Formulation 40 | Beclomethasan Dipropionate USP 0.025% w/w | ||
Clotrimazole IP 1% w/w | ||||
Neomycin Sulphate IP | ||||
Equivalent to Neomycin base 0.50% w/w | ||||
Preservative | ||||
Chlorocresol IP 0.10% w/w | ||||
In a cream base | ||||
41 | Formulation 41 | Clotrimazole BP 1% w/w | 10gm | Topical |
Beclomethasone Dipropionate BP 0.025% w/w | Antifungal | |||
Preservative: | Antibacterial | |||
Chlorocresol IP 0.1% w/w | (Fungal &bacterial | |||
Bronopol BP 0.02% w/w | skin infection) | |||
In Cream base | ||||
42 | Formulation 42 | Betamethasone Dipropionate BP | 20 gm | Anti-inflammatory |
Eq. to Betamethasone BP 0.05% w/w | corticosteroid | |||
Salicylic Acid BP 3.00 w/w | ||||
Urea BP 10.0% w/w | ||||
Lactic Acid BP 3.00% w/w | ||||
Sodium Lactate | ||||
eq.Lactic Acid BP 2.00% w/w | ||||
43 | Formulation 43 | Contains | 30 gm | Corticosteroid |
Beclomethasone | 50 gm | (Steroid responsive | ||
Dipropionate BP 0.025 % w/w | dermatoses such | |||
as allergic or contact | ||||
dermatitis,psoriasis | ||||
seborrhoeic | ||||
Dermatitis procreates | ||||
44 | Formulation 44 | Each gm Contains | 30 gm | Corticosteroid |
Betamethasone | 15 gm | (Steroid responsive | ||
Dipropionate USP 0.05 % w/w | dermatoses such | |||
Eq, to Betamethasone | as allergic or contact | |||
dermatitis,psoriasis | ||||
seborrhoeic | ||||
Dermatitis procreates | ||||
45 | Formulation 45 | Betamethasone Sodium Phosphate USP | 25gm | Corticosteroid |
Eqvt. To Betamethasone 0.1% w/w | ||||
Sterilized Paraffin base q.s | ||||
46 | Formulation 46 | Each gm Contains | 15 gm | Corticosteroid |
Clobetasol Propionate USP 0.05 % w/w | 50 gm | (Steroid responsive | ||
dermatoses such | ||||
as allergic or contact | ||||
dermatitis,psoriasis | ||||
seborrhoeic | ||||
Dermatitis procreates | ||||
47 | Formulation 47 | Clobetasol Propionate BP 0.05% w/w | 25gm | |
Ointment base | ||||
48 | Formulation 48 | Betamethasone Valerate BP | 15gm | Corticosteroid |
Equivalent to Betamethasone 0.1% w/w | ||||
Chlorocresol BP (As preservative) 0.1% w/w | ||||
Ointment base q.s | ||||
49 | Formulation 49 | Betamethasone Valerate BP | ||
eq. to Betamethasone 0.1% w/v | ||||
50 | Formulation 50 | Composition: | 20 gm | Antifungal |
Clotrimazole BP 1 w/w | Antibacterial | |||
51 | Formulation 51 | Clotrimazole USP 1.0% w/w | 50gm | |
Cream base Q.S. | ||||
52 | Formulation 52 | Each gm Contains: | 30gm | Candidal & trichomonal |
Clotrimazole USP 2% w/w | Vaginitis | |||
53 | Formulation 53 | Each gm Contains | 20 gm | Antifungal |
Tolnaftate USP 1 % w/w | Antibacterial | |||
54 | Formulation 54 | Each ml contains: | 10ml | Antifungal |
Tolnaftate USP …. 1%w/w | Antibacterial | |||
55 | Formulation 55 | Contains | 30 gm | Local anesthetic |
Lignocaine Hydrochloride IP 2.0 % w/w | ||||
Methylparaben IP 0.10% w/v | ||||
( as preservative ) | ||||
Propyl paraben IP 0.05% w/v | ||||
( as preservative ) | ||||
In water miscible base | ||||
56 | Formulation 56 | Composition | 30gm | Local anesthetic |
Lignocaine Hydrochloride IP equt to | ||||
Anhydrous Lignocaine | ||||
Hydrochloride 2.000%w/v | ||||
Methylparaben IP (As preservative) | ||||
0.061% w/v | ||||
Propylparaben IP (As preservative) | ||||
0.027% w/v | ||||
Water –soluble gel base in | ||||
Purified water IP ……..q.s | ||||
57 | Formulation 57 | Each ml Contains | 10 ml | Local anesthetic |
Lidocaine Hydrochloride I.P. 42.66 mg | ||||
Methyl Paraben IP 0.1% w/v. | ||||
Propyl Paraben IP 0.05% w/v. | ||||
(An Preservative) | ||||
58 | Formulation 58 | Lidocaine Hydrochloride BP 2%w/v | 30gm | Local anesthetic |
(Anhydrous) | ||||
Methyl Paraben USP 0.10%w/v | ||||
(As Preservative) | ||||
Propyl Paraben USP 0.05%w/v | ||||
(As Preservative) | ||||
In water Miscible Base q.s. | ||||
59 | Formulation 59 | Lidocaine USP 2.5% w/w | 30gm | Local anesthetic |
Ointment base q.s | ||||
60 | Formulation 60 | Lidocaine USP 5% w/w | 30gm | Local anesthetic |
Ointment base q.s | ||||